A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Prednicarbate
Hydrocortisone butyrate
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Hydrocortisone butyrate.
Prednicarbate
Cortisone
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Cortisone.
Prednicarbate
Betamethasone phosphate
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Betamethasone phosphate.
Prednicarbate
Melengestrol acetate
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Melengestrol acetate.
Prednicarbate
Clocortolone acetate
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Clocortolone acetate.
Prednicarbate
Prednisone acetate
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Prednisone acetate.
Prednicarbate
Methylprednisolone hemisuccinate
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Methylprednisolone hemisuccinate.
Prednicarbate
Prednisolone hemisuccinate
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Prednisolone hemisuccinate.
Prednicarbate
Prednisolone phosphate
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Prednisolone phosphate.
Prednicarbate
Hydrocortisone succinate
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Hydrocortisone succinate.
Prednicarbate
Hydrocortisone cypionate
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Hydrocortisone cypionate.
Prednicarbate
Hydrocortisone acetate
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Hydrocortisone acetate.
Prednicarbate
Mometasone furoate
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Mometasone furoate.
Prednicarbate
Fluticasone
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Fluticasone.
Prednicarbate
Fluclorolone
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Fluclorolone.
Prednicarbate
Cloprednol
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Cloprednol.
Prednicarbate
Fluperolone
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Fluperolone.
Prednicarbate
Fluocortin
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Fluocortin.
Prednicarbate
Prednylidene
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Prednylidene.
Prednicarbate
Cortivazol
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Cortivazol.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3